Solera Health and WellDoc Announce Partnership

Solera Health, an integrated benefit network, and WellDoc, a leading digital therapeutic company, announced this week that WellDoc’s BlueStar digital therapeutic will join the Solera network as a diabetes management solution of choice.

The partnership aligns both companies’ goals to improve the lives of those living with chronic diseases while enhancing clinical results and decreasing overall healthcare costs.

Solera Health connects patients, payers and physicians with community organizations and digital therapeutics providers delivering evidence-based prevention, coping and support services. The company’s national and scalable model of integrating highly fragmented non-medical programs and services into an integrated network helps individuals identify the “best fit” program provider based on their unique needs and preferences.

Solera’s model is driving industry-leading sustained engagement and outcomes and lessening the administrative burden for payers to access a broad network of high-performing solutions providers.

“The addition of BlueStar to our network of evidence-based solution providers enables Solera to offer a broader, more comprehensive approach to diabetes prevention and management that drives sustained consumer engagement and clinical outcomes,” said Brenda Schmidt, CEO of Solera Health. “WellDoc is an ideal partner to help fill this need as BlueStar delivers impressively on both — individual commitment and clinically-validated results — as evidenced by the data we’ve seen to date.”

This post was written by:

- who has written 626 posts on mHealthWatch.

Contact the author